Qing Wei Selected Research

human MIRN206 microRNA

1/2022

hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Wei Research Topics

Disease

56	Neoplasms (Cancer) 10/2022 - 01/2006
19	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2015
11	Carcinogenesis 01/2021 - 09/2006
7	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2015
7	Hypoxia (Hypoxemia) 01/2022 - 05/2013
6	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 12/2013
6	Adenocarcinoma 12/2021 - 05/2006
6	Infections 01/2020 - 01/2002
5	Inflammation (Inflammations) 01/2022 - 01/2018
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2009
4	Ciliopathies 12/2020 - 11/2012
4	Agenesis of Cerebellar Vermis 01/2020 - 06/2010
4	Disease Progression 01/2018 - 11/2009
3	Floating-harbor syndrome 01/2021 - 02/2019
3	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2019
3	Thyroid Nodule (Nodule, Thyroid) 01/2020 - 08/2009
3	Carcinoma (Carcinomatosis) 01/2020 - 05/2013
3	Diarrhea 01/2020 - 01/2017
3	Memory Disorders (Memory Loss) 01/2015 - 11/2013
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2022 - 03/2014
2	Hemorrhage 10/2022 - 05/2015
2	Wounds and Injuries (Trauma) 01/2022 - 08/2021
2	Dermatomyositis (Dermatopolymyositis) 01/2022 - 07/2020
2	Stroke (Strokes) 03/2021 - 01/2019
2	COVID-19 01/2021 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2020
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/2020 - 12/2018
2	Calcinosis 08/2020 - 11/2018
2	Hydrolethalus syndrome 01/2020 - 01/2016
2	Multiple Myeloma 01/2020 - 01/2013
2	Papillary Thyroid Cancer 01/2020 - 08/2009
2	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 11/2015
2	Lymphoma (Lymphomas) 02/2019 - 04/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2019 - 05/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 09/2015
2	Colitis 01/2018 - 01/2017
2	Body Weight (Weight, Body) 01/2018 - 09/2013
2	Choriocarcinoma 07/2008 - 11/2007

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2010
15	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2006
12	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2002
11	MicroRNAs (MicroRNA)IBA 10/2022 - 01/2015
9	Biological ProductsIBA 04/2020 - 01/2006
5	InflammasomesIBA 07/2019 - 01/2014
4	Immune Checkpoint InhibitorsIBA 10/2022 - 08/2020
4	Long Noncoding RNAIBA 01/2022 - 01/2016
4	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2013
4	LipidsIBA 11/2021 - 02/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2002
4	AntigensIBA 03/2019 - 04/2004
4	Messenger RNA (mRNA)IBA 02/2019 - 09/2013
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2015 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2011
3	AntioxidantsIBA 01/2022 - 01/2019
3	Phosphotransferases (Kinase)IBA 12/2021 - 06/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2020
3	Gefitinib (Iressa)FDA Link 01/2021 - 11/2009
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 12/2013
3	ChromatinIBA 01/2020 - 05/2013
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2011
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2013
3	Piwi-Interacting RNAIBA 01/2020 - 01/2018
3	EnzymesIBA 01/2019 - 11/2012
3	CateninsIBA 01/2019 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2016 - 01/2011
2	InterleukinsIBA 01/2022 - 07/2020
2	Cadherins (E-Cadherin)IBA 01/2022 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 07/2020
2	Protein Kinases (Protein Kinase)IBA 12/2021 - 11/2015
2	Neuroprotective AgentsIBA 04/2021 - 04/2019
2	GlucocorticoidsIBA 01/2021 - 05/2014
2	Hormones (Hormone)IBA 01/2021 - 01/2019
2	CytokinesIBA 01/2021 - 08/2014
2	Insulin (Novolin)FDA Link 01/2021 - 01/2013
2	IntegrinsIBA 01/2021 - 12/2019
2	NucleotidesIBA 10/2020 - 05/2006
2	Capsules (Microcapsules)IBA 08/2020 - 11/2018
2	Adenosine Monophosphate (AMP)IBA 08/2020 - 01/2020
2	LipopolysaccharidesIBA 01/2020 - 01/2018
2	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020 - 01/2006
2	Estrogen ReceptorsIBA 07/2019 - 07/2015
2	AzoxymethaneIBA 04/2019 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2017
2	Dextrans (Dextran)FDA Link 01/2018 - 01/2017
2	AntibodiesIBA 01/2016 - 04/2004
2	SeleniumIBA 01/2015 - 11/2013
2	LuciferasesIBA 09/2014 - 05/2013
2	UbiquitinIBA 11/2012 - 05/2006
2	contrast agent BR1IBA 07/2008 - 11/2007
2	Contrast MediaIBA 07/2008 - 11/2007

Therapy/Procedure

15	Therapeutics 10/2022 - 12/2011
10	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
4	Aftercare (After-Treatment) 04/2019 - 12/2009
2	Immunotherapy 10/2022 - 01/2022
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2020
2	Length of Stay 01/2022 - 02/2016
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2017 - 01/2015